Dihydroxyanthraquinone and related bis(substituted) aminoanthraquinones: a novel class of antitumor agents.
D000818:Animals; D000880:Anthraquinones / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D000970:Antineoplastic Agents; D002451:Cell Compartmentation; D002453:Cell Cycle / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003131:Combined Modality Therapy; D005609:Free Radicals; D007364:Intercalating Agents / Q000627:therapeutic use; D009696:Nucleic Acids / Q000096:biosynthesis; D014176:Protein Biosynthesis; D013329:Structure-Activity Relationship
D000880:Anthraquinones; D000970:Antineoplastic Agents; D005609:Free Radicals; D007364:Intercalating Agents; D009696:Nucleic Acids